ANDREA ENTERS: Open Payments
NPI 1336540418 · SUSSEX, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,226
Food & beverage: $1,226
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 3 | $274 |
| ARGENX US, INC. | 2 | $244 |
| Janssen Biotech, Inc. | 2 | $154 |
| Amgen Inc. | 3 | $136 |
| TG Therapeutics, Inc. | 1 | $122 |
| Alnylam Pharmaceuticals Inc. | 1 | $121 |
| Biogen, Inc. | 4 | $78 |
| UCB, Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 1 | $37 |
| Lundbeck LLC | 1 | $16 |
Products named: VYVGART, ULTOMIRIS, BRIUMVI, AMVUTTRA, LEQEMBI, Rystiggo, Truxima, TYSABRI.
Industry payments across WI — which companies pay providers there.
